
IVVD
Healthcare · Biotechnology · $171.6M market cap
$0.5821+0.01 (+2.6%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -15.4% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | -0.11 | — | — |
| Aug 13, 2026 | After the close | -0.15 | -0.14 | +6.7% |
| May 14, 2026 | Before the open | -0.08 | -0.13 | -62.5% |
| Mar 26, 2026 | Time not confirmed | -0.09 | -0.04 | +54.5% |
| Nov 6, 2025 | Before the open | -0.09 | -0.06 | +33.3% |
| Aug 14, 2025 | After the close | 0.01 | -0.12 | -1300.0% |
| May 15, 2025 | Before the open | -0.04 | -0.14 | -250.0% |
| Mar 26, 2025 | Before the open | -0.10 | -0.15 | -50.0% |
| Nov 14, 2024 | Before the open | -0.35 | -0.51 | -45.7% |
| Aug 14, 2024 | Before the open | -0.39 | -0.40 | -2.6% |
| May 9, 2024 | After the close | -0.39 | -0.38 | +2.6% |
| Mar 28, 2024 | Before the open | -0.42 | -0.67 | -59.5% |
| Nov 9, 2023 | After the close | -0.50 |
Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the…
| -0.36 |
| +28.0% |
| Aug 10, 2023 | After the close | -0.45 | -0.46 | -2.2% |
| May 11, 2023 | After the close | -0.48 | -0.32 | +33.3% |
| Mar 23, 2023 | After the close | -0.39 | -0.25 | +35.9% |
| Nov 10, 2022 | After the close | -0.37 | -0.42 | -13.5% |
| Aug 15, 2022 | Before the open | -0.50 | -0.47 | +6.0% |
| May 13, 2022 | Before the open | -0.56 | -0.91 | -62.5% |
| Mar 30, 2022 | Before the open | -1.03 | -0.77 | +25.2% |
| Nov 15, 2021 | After the close | -0.57 | -0.89 | -56.1% |
| Sep 20, 2021 | After the close | -0.80 | -0.18 | +77.5% |
| Jun 2, 2021 | Time not confirmed | -0.60 | -2.14 | -256.7% |